scispace - formally typeset
W

Wade V. Welshons

Researcher at University of Missouri

Publications -  99
Citations -  17891

Wade V. Welshons is an academic researcher from University of Missouri. The author has contributed to research in topics: Estrogen receptor & Estrogen. The author has an hindex of 51, co-authored 99 publications receiving 16524 citations. Previous affiliations of Wade V. Welshons include University of California, San Francisco & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

Human exposure to bisphenol A (BPA).

TL;DR: The reported levels of BPA in human fluids are higher than the BPA concentrations reported to stimulate molecular endpoints in vitro and appear to be within an order of magnitude of the levels needed to induce effects in animal models.
Journal ArticleDOI

Large Effects from Small Exposures. III. Endocrine Mechanisms Mediating Effects of Bisphenol A at Levels of Human Exposure

TL;DR: Concern with human exposure to BPA derives from identification of molecular mechanisms mediating effects in human and animal tissues at very low doses, in vivo effects in experimental animals caused by low doses within the range of human exposure, and widespread human Exposure to levels of BPA that cause adverse effects in animals.
Journal ArticleDOI

Nuclear localization of unoccupied oestrogen receptors.

TL;DR: It is found that cytoplasts prepared from GH3 cells contain little oestrogen-binding activity and that most of the unfilled oestrogens receptors are associated with the nuclear fraction, suggesting that the standard model is in error and that the unoccupied receptor is nuclear in the intact cell.
Journal ArticleDOI

Large Effects from Small Exposures. I. Mechanisms for Endocrine-Disrupting Chemicals with Estrogenic Activity

TL;DR: Four fundamental issues are problematic for risk assessment methods used by regulatory agencies, because they challenge the traditional use of extrapolation from high-dose testing to predict responses at the much lower environmentally relevant doses.